Pressure Biosciences Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pressure Biosciences Inc 's ROA in the second quarter of 2024?
Pressure Biosciences Inc recorded a cumulative net loss of $-31 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -761.17%.

However, within the Healthcare sector 1036 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2024 quarter, so far to 5110, from total ROA ranking in the first quarter of 2024 at 5232.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	301.59 %	208.79 %	-45.92 %	-18.9 %	-39.22 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-31	-35	-34	-27	-26
Return On Assets (TTM)	-761.17 %	-1189.26 %	-1938.02 %	-1418.8 %	-1278.21 %
PBIO's Total Ranking	# 5110	# 5232	# 6001	# 5405	# 5514
Total Assets (TTM) in million	6	7	1	2	2
Seq. Total Assets Change	-9.87 %	628.56 %	-53.68 %	32.04 %	-30.7 %
Seq. Net Income Change	-	-	-	-	-

PBIO's 5 Years Annual ROA >> Back to PBIO Management Effectiveness >> Compare PBIO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 30
Sector	# 1037
Overall	# 5011

Return On Assets Statistics
High	Average	Low
55.49 %	-593.67 %	-2052.98 %
(Mar 31 2017)		(Dec 31 2023)

Financial Statements
Pressure Biosciences Inc 's Assets	$ 6 million	PBIO's Balance sheet
Pressure Biosciences Inc 's Income	$ -7 million	Quarterly PBIO's Income Statement
PBIO's Income by Division		See PBIO's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-45.92 %	-38.08 %	38.97 %	19.66 %	-27.52 %
Total Assets in million	1	2	3	2	2
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-33	-16	-21	-16	-14
Annual Return On Assets	-3400.59 %	-897.57 %	-726.97 %	-771.94 %	-822.92 %

PBIO's 5 Years Annual ROA >> Back to PBIO Management Effectiveness >> Compare PBIO ROA to its Competitors

More Return On Assets Ratios
PBIO's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PBIO's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PBIO's Competitors
Subscribers only: Roa for Pressure Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for PBIO's Customers

You may also want to know
PBIO's Roi	PBIO's Inventory Turnover Ratio	PBIO's Growth Rates	PBIO's Dividend Comparisons
	PBIO's Profitability Ratios	PBIO's Asset Turnover Ratio	PBIO's Dividend Growth
PBIO's Roe	PBIO's Valuation Ratios	PBIO's Financial Strength Ratios	PBIO's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.